DANVERS, MA - Samsung is pleased to announce that its full line of computed tomography systems, including BodyTom® and CereTom®, are compliant with Medical Imaging & Technology Alliance (MITA) Smart Dose (XR-29) radiation dose reporting standards. All new systems sold are 100% compliant, and any installed system can easily be upgraded to include these new features. National Electrical Manufacturers Association (NEMA) XR-29, also known as the MITA Smart Dose Standard, is a quality initiative to promote patient safety and public health in CT diagnostic imaging. Samsung is dedicated to customer centric innovation and providing the industry with the tools and resources they need to keep patients and clinicians safe.
NEMA Standard XR-29 identifies common CT system attributes that contribute to or help perform dose optimization/management of ionizing radiation while still enabling the system to deliver the diagnostic image quality needed by the physician. These attributes include DICOM radiation dose structured reporting, pediatric and adult reference protocols, CT dose check, and automatic exposure control. The intent of this new standard is to ensure patient safety and provider compliance that elevates the quality of care.
“Samsung fully supports the MITA Smart Dose Standard and ensuring that our CT systems meet this critical new industry standard was an important objective that we are pleased to have achieved. We understand the need to deliver high diagnostic image quality at the lowest dose required. Samsung prides itself on designing solutions for radiation dose management, always with patient safety in mind” said Philip Sullivan, Samsung, NeuroLogica Division, President & CEO.
Samsung will showcase its dose management solutions in booth #7313 at the Radiological Society of North America Annual Meeting (RSNA), November 29th through December 4th in Chicago, IL. Visit www.samsung.com/RSNA2015 and follow @SamsungHealthUS for more information on Samsung’s presence at #RSNA2015.
About NeuroLogica
NeuroLogica, a healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please see visit, www.SamsungNeuroLogica.com
About Samsung Electronics Co., Ltd.
Samsung Electronics Co., Ltd. inspires the world and shapes the future with transformative ideas and technologies, redefining the worlds of TVs, smartphones, wearable devices, tablets, cameras, digital appliances, printers, medical equipment, network systems, and semiconductor and LED solutions. We are also leading in the Internet of Things space through, among others, our Smart Home and Digital Health initiatives. We employ 307,000 people across 84 countries with annual sales of US $196 billion. To discover more, please visit our official website at www.samsung.com and our official blog at global.samsungtomorrow.com.
CONTACTS:
Lynne Gagne
978-564-8576
lgagne@samsungneurologica.com